Previous Article | Next Article 
Antimicrobial Agents and Chemotherapy, February 1998, p. 352-357, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Mechanism of Amphotericin B Resistance in
Leishmania donovani Promastigotes
Nicolas
Mbongo,1
Philippe M.
Loiseau,2,*
Marie A.
Billion,1 and
Malka
Robert-Gero1
Institut de Chimie des Substances Naturelles,
CNRS, F-91190, Gif sur Yvette,1 and
Biologie et Contrôle des Organismes Parasites,
Faculté de Pharmacie, Université de Paris-Sud, F-92296,
Châtenay-Malabry,2 France
Received 23 June 1997/Returned for modification 17 November
1997/Accepted 3 December 1997
 |
ABSTRACT |
Amphotericin B (AmB)-resistant Leishmania donovani
promastigotes were selected by increasing drug pressure, and their
biological features were compared with those of the wild-type parent
strain. The 50% inhibitory concentration for resistant cells was 20 times higher than that for the wild-type. Resistance was stable after more than 40 passages in drug-free medium, and resistant promastigotes were infective to macrophages in vitro but lost their virulence in
vivo. They had 2.5 times longer generation time, decreased AmB uptake,
and increased AmB efflux in comparison to the wild type. Fluorescence
measurement with a specific plasma membrane probe,
1-[4-(trimethylammonio)-1,6-diphenylhexa]-1,3,5-triene, showed
increased membrane fluidity in drug-resistant promastigotes. Analysis
of lipid composition showed that in resistant cells saturated fatty
acids were prevalent, with stearic acid as the major fatty acid, and
the major sterol was an ergosterol precursor, the cholesta-5, 7, 24-trien-3
-ol and not ergosterol as in the AmB-sensitive strain.
 |
INTRODUCTION |
Leishmania donovani, a
protozoan parasite, is the causative agent of visceral leishmaniasis, a
disease which is fatal in the absence of treatment. Its incidence is
about 0.5 million cases annually (28). Pentavalent
antimonials (Pentostam and Glucantime) are the first-line drugs, but
refractory strains to these drugs are increasingly prevalent in areas
of endemicity (26, 33). Amphotericin B (AmB) is a polyene
antibiotic which binds preferentially to ergosterol, the major sterol
of fungi, Leishmania, and Trypanosoma cruzi. This
antibiotic is a second-line treatment for leishmaniasis (1),
but side effects limit its use. Recently, AmB-lipid formulations (AmBisome and Amphocil) have been developed with reduced toxicity and
an improved therapeutic index. They represent an alternative for the
treatment of visceral leishmaniasis (6, 23, 31). As AmB
formulations are increasingly being used for the treatment of visceral
leishmaniasis and probably mucocutaneous leishmaniasis, we decided to
investigate the development and mechanism of resistance. Resistance to
AmB is uncommon in fungi but has been reported previously (16). The aim of our work was to establish a line of
AmB-resistant L. donovani promastigotes in vitro and to
study the molecular basis of this resistance.
 |
MATERIALS AND METHODS |
Chemical compounds.
AmB, cholic acid,
bis(trimethylsilyl)trifluoroacetamide (BSTFA), allopurinol riboside,
and paromomycin were purchased from Sigma Chemicals (Saint Quentin
Fallavier, France). Ketoconazole was purchased from ICN Biomedicals
(Orsay, France). Pentamidine isethionate was a gift from Roger Bellon
(Neuilly sur Seine, France). Taxotere was a gift from P. Potier (ICSN,
Gif sur Yvette, France). Difluoromethylornithine (DFMO) was a gift from
Merrel Dow (Strasbourg, France). Sinefungin was purchased from
Rhône-Poulenc Rorer (Vitry sur Seine, France). Boron trifluoride
etherate was purchased from Fluka AG (Buchs, Switzerland), and
analytical grade (high-performance liquid chromatography [HPLC])
acetonitrile and methanol were obtained from SDS (Peypin, France). Nile
red reagent and
1-[4-(trimethylammonio)-1,6-diphenylhexa]-1,3,5-triene (TMA-DPH) were
purchased from Molecular Probes (Eugene, Oreg.).
Isolation of AmB-resistant Leishmania.
AmB-resistant
clones were obtained from wild-type L. donovani DD8
promastigotes (strain MHOM/IN/80/DD8) by increasing drug concentration
in culture medium as previously described for sinefungin (29).
Determination of AmB content of treated promastigotes. (i)
Parasite treatment and cell extracts.
Promastigotes were cultured
in Erlenmeyer flasks at an initial density of 0.5 × 106 to 1 × 106 promastigotes/ml in 50 ml
of RPMI 1640 medium (Gibco, Eragny, France) with 10% inactivated fetal
calf serum supplemented with 2 mM glutamin and streptomycin (5 µg/ml)
and penicillin (5 IU/ml). Flasks were placed in an orbital incubator
(Gallenkamp) under continuous shaking (150 rpm) at 27°C. When
Leishmania cultures reached a density of 20 × 106 to 25 × 106/ml (logarithmic phase)
various concentrations of the drug were added, and cells were incubated
for 2 h. Promastigotes were harvested by centrifugation and washed
twice with large volumes of cold phosphate-buffered saline (PBS; pH
7.5). Pellets were resuspended in 200 µl of an aqueous solution of 20 mM cholic acid for 24 h at 4°C and then centrifuged (11,000 × g, 1 h, 4°C). An equal volume of cold ethanol was
added to the supernatant, and the mixture was kept in an ice bath for
1 h to precipitate the proteins. The samples were then centrifuged
(11,000 × g, 1 h, 4°C), and 150 to 200 µl of
the clear supernatant was analyzed by HPLC for AmB determination.
HPLC analysis.
Reverse-phase chromatography analysis on a
Novapack C18 reversed-phase column (3.9 by 150 mm.) was performed by
previously described methods (4, 18) with a liquid
chromatograph equipped with a solvent delivery system control (Waters
600 E; Millipore), a Waters 717 plus Autosampler with temperature
control system (4°C for AmB samples), and a photodiode array detector
and reporting integrator (Waters 990). The detection was at 408 nm,
corresponding to the maximum absorbance for AmB. The mobile phase was
an isocratic gradient of 5 mM EDTA-acetonitrile (60:40, vol/vol)
delivered at a flow rate of 1 ml/min. The 5 mM EDTA solution was made
in PBS and adjusted to pH 7.05 with orthophosphoric acid. Standard concentrations of 0.0125, 0.125, 0.25, 0.5, 1, and 5 µM were made by
dissolving AmB in mobile phase or methanol. Detection limit was found
at 0.5 pmol/mg of protein.
Drug efflux.
Leishmania promastigotes treated with
drug were harvested as mentioned above and transferred to fresh
drug-free medium and incubated for various times prior to extraction.
Fluorescent probes.
TMA-DPH was prepared as a 2 mM stock
solution in dimethylformamide and was stored at 4°C. An intermediate
dilution of 50 µM was prepared daily from the 2 mM stock with PBS,
agitated vigorously for 10 min to eliminate the solvent, and used for
staining. Nile red was prepared at 100 µg/ml (0.3 µM) in acetone
and was conserved at 4°C in a dark environment.
Determination of membrane fluidity by flow cytometry.
AmB-resistant and wild-type promastigotes were diluted with PBS to a
cellular density of 107 promastigotes/ml and then stained
with 2 µM TMA-DPH for 2 min before being analyzed by flow cytometry.
Membrane fluidity was assessed by measurement of the fluorescence
anisotropy (r) of TMA-DPH following its insertion into the
plasma membrane of promastigotes (9, 11). The EPICS flow
cytometer (Coulter, Hialeah, Fla.) had a 100-µm-diameter nozzle and
standard optics such that each cell was exposed and measured for about
1.5 µs, i.e., 2 orders of magnitude above the fluorescence lifetime
of these probes. The argon laser (Spectra-Physics 2025-05) with
vertically polarized output was set at 351 to 364 nm and 50 mW. The
signals were processed on an analog card linked to a 1,024-channel
analog-to-digital converter (ADC) to derive the blue emission
anisotropy (r) as previously described (30). The
forward-angle light scatter was used to gate the analysis upon intact
cells. The mean r value was calculated for 10,000 cells.
Determination of lipids.
AmB-resistant and wild-type
promastigotes were prepared as described above for fluidity
measurements, stained with Nile red (100 ng/ml) for 5 min, and then
individually analyzed by flow cytometry. The excitation wavelength of
the same argon laser was set at 488 nm and 400 mW. The fluorescent
emission was filtered through a 515-nm long-pass filter (interference
and absorbance) and split with a 590-nm dichroic mirror, sending the
red component through a 610-nm long-pass filter to one photomultiplier
and the yellow component through a 560-nm short-pass filter to another photomultiplier. Cellular fluorescence in the absence of dye was negligible. In each analysis, 10,000 promastigotes were studied. The
intensities of red and yellow fluorescence were measured as previously
described (21).
Extraction and analysis of free sterols and fatty acids.
Promastigotes were grown as described above in three Erlenmeyer flasks
in a total volume of 1 liter of culture medium. For cell treatment a
volume of drug in 10% dimethyl sulfoxide in water corresponding to an
appropriate final concentration was added, and cultures were incubated
at 27°C for various times at 150 rpm in an orbital incubator
(Gallenkamp). Cells were harvested, washed, and pooled, and the pellet
was resuspended in 20 ml of dichloromethane-methanol (2:1, vol/vol) for
about 24 h at 4°C. After centrifugation (11,000 × g, 1 h, 4°C) the extract was evaporated under vacuum.
The residue and the pellet were saponified with 30% KOH in methanol at
80°C for 2 h. Sterols were extracted with petroleum ether, which
was thereafter evaporated, and the residue was dissolved in
dichloromethane. An aliquot of clear yellow sterol solution was added
to 2 volumes of BSTFA, and the sealed tubes were heated at 80°C for
1 h. The trimethylsilyl (TMS) ethers of sterols were subjected to
gas chromatography/mass spectrometry (GC/MS) analysis following
previously described methods with some modifications (10, 19,
22).
Aqueous phases of KOH methanolic extracts were acidified with 6 N
sulfuric acid to pH 3. Fatty acids were extracted with petroleum ether
and diethyl ether and transesterified by BF3-methanol at room temperature for 2 h. Methyl esters were extracted with
diethyl ether, redissolved in methanol-diethyl ether (1:1) prior to
gas-liquid chromatography (GLC)/MS analysis.
GLC was performed with a Varian model 3400 chromatograph equipped with
DB5 columns (methyl/phenylsiloxan ratio, 95/5; dimensions, 30 m by
0.25 mm). The gas carrier was He (1 ml/min). Analysis conditions were
as follows: the column was kept at 270°C, the injector was kept at
300°C (splitless), and the detector was kept at 300°C (isothermic
conditions for sterols). The linear gradient for methyl esters was from
150 to 180°C at 10°C/min. MS conditions were 280°C, 70 eV, and
2.2 kV.
Infectivity test. (i) In vitro.
Infectivity of AmB-resistant
promastigotes was determined classically with mouse peritoneal
macrophages.
(ii) In vivo.
Female BALB/c mice, 18 to 20 g (Charles
River, Cléon, France), were infected by the retroorbital sinus
route with 108 AmB-sensitive or AmB-resistant
promastigotes. Mice were sacrificed 4 weeks after infection. As
L. donovani DD8 is poorly infective for animals, subcultures
of liver and spleen were performed.
 |
RESULTS |
Phenotype of AmB-resistant promastigotes and in vivo
infectivity.
The growth rate of AmB-resistant promastigotes was
slower (doubling time, 20 h) than that of the wild-type (doubling
time, 8 h). The 50% inhibitory concentration of AmB was 20 times
higher for resistant cells than for the wild-type. Resistant
promastigotes responded to all drugs tested with a slightly decreased
sensitivity to DFMO, sinefungin, and allopurinol and a significantly
increased sensitivity to ketoconazole (Table
1). They were still able to infect
macrophages in vitro but lost their virulence in vivo, since the
subcultures of liver and spleen were negative for the AmB-resistant
strain and positive for the AmB-sensitive strain. Furthermore, AmB
resistance was conserved after culture in drug-free medium for more
than 60 days.
View this table:
[in this window]
[in a new window]
|
TABLE 1.
Effects of different drugs on in vitro growth of
AmB-sensitive and AmB-resistant L. donovani DD8
promastigotes after a 72-h incubation period at 27°C
|
|
Uptake of AmB in sensitive and resistant promastigotes.
The
intracellular AmB content in the L. donovani DD8 wild type
increased with the incubation time, whereas that of the resistant (R)
cells increased slowly up to 8 h and decreased afterward (Fig. 1). As a function of extracellular AmB
concentration, uptake was linear for wild-type promastigotes whereas
for resistant promastigotes, the saturation was reached at 0.3 µM
(Fig. 2).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
Accumulation of AmB in L. donovani
DD8-sensitive (S) and -resistant (R) promastigotes after incubation
with 0.2 µM AmB. Values are means of three independent experiments,
and standard deviations are represented by error bars.
|
|

View larger version (11K):
[in this window]
[in a new window]
|
FIG. 2.
Accumulation of AmB in L. donovani
DD8-sensitive (A) and -resistant (R) promastigotes treated for 2 h. Values are means of three independent experiments, and standard
deviations are represented by error bars.
|
|
Efflux of AmB from sensitive and resistant promastigotes.
No
significant change was observed in the intracellular AmB content of
wild-type promastigotes treated with 0.2 µM of the drug for 2 h
(Fig. 3). Under the same conditions,
efflux of AmB from resistant promastigotes in drug-free culture medium
increased as a function of incubation time, and no intracellular
concentration was detected after 60 min (Fig. 3). However, when treated
with 1 or 2 µM AmB this efflux was slow (data not shown).

View larger version (29K):
[in this window]
[in a new window]
|
FIG. 3.
Efflux of AmB from treated L. donovani
DD8-sensitive (S) and -resistant (R) promastigotes for 2 h at 0.2 µM. Error bars indicate standard deviation.
|
|
Lipids and membrane fluidity.
The emission anisotropy value of
AmB-resistant Leishmania promastigotes was five times lower
than that of the wild-type promastigotes, indicating differences in the
TMA-DPH environment within the plasma membranes of these cells. The
membrane of AmB-resistant cells is therefore more fluid than that of
AmB-sensitive cells (Table 2). This
change in membrane fluidity is probably a consequence of the
resistance-induced modification of membranous lipid metabolism. Nile
red is a vital dye that emits a predominantly red fluorescence in polar
hydrophobic domains (phospholipids) and a yellow fluorescence in
neutral hydrophobic domains (14). Promastigotes in the
logarithmic phase of growth, stained with Nile red and examined by
light microscopy, showed that yellow fluorescence was emitted by
intracytoplasmic lipidic droplets, whereas red fluorescence was
localized in the membrane. No significant difference was observed
between sensitive and resistant cells concerning membrane
phospholipids, whereas the cytoplasm of AmB-resistant promastigotes
contains less neutral lipids than that of the wild type.
View this table:
[in this window]
[in a new window]
|
TABLE 2.
Effects of AmB resistance on the fluorescence of
exponential-phase L. donovani promastigotes labeled with
Nile red and on the membrane fluidity of promastigotes as assessed by
emission anisotropy of TMA-DPHa
|
|
Free sterol and fatty acid composition of L. donovani.
GC/MS analysis showed that ergosterol (30%) and its isomer, ergosta-5,
7, 24 (28)-trien-3
-ol (32%), represent 62% of total sterols in
untreated wild-type promastigotes at logarithmic-growth phase, whereas
in AmB-resistant promastigotes, the major sterol is cholesta-5, 7, 24-trien-3
-ol (58%). These values increased in the stationary phase
of culture (Table 3).
In ketoconazole-treated promastigotes, the sterol composition of
AmB-resistant promastigotes, showed the following accumulation
of
methyl sterols: 14

-methylcholesta-8, 24-dien-3

-ol, 33%; 4

,
14

-cholesta-8, 24-dien-3

-ol, 5%; 14

-methylcholesta-5, 7, 24-trien-3

-ol,
4%; 4

, 4-dimethylcholesta-8, 24-dien-3

-ol, 3%
(Table
4). The
corresponding accumulation for similarly treated
wild-type promastigotes
was as follows: 14

-methylergosta-5, 7, 24 (28)-trien-3

-ol, 35%;
4

, 14

-dimethylergosta-8,
24-dien-3

-ol, 4%; 14

-methylergosta-8,
24 (28)-dien-3

-ol (1%)
(Table
4). Mass spectra for the TMS ether
derivatives are given in Table
5.
Fatty acid composition was also different between the two cell types:
stearic acid was the major fatty acid in resistant cells,
whereas in
wild-type cells, the unsaturated fatty acids were prevalent
(Table
6).
 |
DISCUSSION |
Results presented in this paper provide some information on the
mechanisms developed by L. donovani promastigotes to reduce the lethal effect of AmB. This resistance is stable even in the absence
of drug pressure. The resistance observed to DFMO, sinefungin, and
allopurinol riboside as well as the increased sensitivity to
ketoconazole is probably related to altered membrane permeability as a
consequence of the AmB-induced resistance.
Wild-type L. donovani promastigotes take up AmB for at least
24 h. In contrast, AmB uptake in resistant promastigotes reached a
maximum value after 8 h of incubation and then decreased. An obvious efflux of AmB was observed in resistant promastigotes.
Sterols of Leishmania species have been previously studied,
and common characteristics in biosynthetic pathways have been found
between Leishmania and fungi (12, 13).
Cholesterol is taken up from the culture medium but is not metabolized
by promastigotes in either ketoconazole-treated or untreated cultures.
In the L. donovani wild type, ergosterol and its
isomer [ergosta-5, 7, 24 (28)-trien-3
-ol] were
present in the same proportion and were the major
sterols, while in AmB-resistant promastigotes, the major sterol
was cholesta-5, 7, 24-trien-3
ol, which could
produce ergosterol isomer by C-24 transmethylation. However, ergosterol
was not detected. AmB-resistant Leishmania are therefore
defective in C-24 transmethylation of C-27 sterols. This is consistent
with the absence of C-28 sterols observed in resistant promastigotes
(Fig. 4).

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 4.
Proposed biosynthetic pathway of ergosterol in L. donovani. Symbols: , pathway of wild-type promastigotes; ,
pathway of AmB-resistant promastigotes; , sites
inhibited by ketoconazole; ...... , defective
24-methyltransferase in AmB-resistant promastigotes.
|
|
The analysis of sterol composition of wild-type promastigotes in
stationary phase shows that the major sterols increased slightly and
certain ergosterol precursors that were not observed at logarithmic phase accumulated. In AmB-resistant stationary-phase promastigotes, the
major sterol, cholesta-5, 7, 24-trien-3
-ol, increased with the
subsequent reduction of certain sterols.
These differences in sterol composition between logarithmic and
stationary phases were expected and were also observed in Candida
albicans (24).
L. donovani wild-type promastigotes were less sensitive to
ketoconazole than were AmB-resistant cells. However, in both cell types
the azole inhibited C-14 demethylation, as in fungi (34). In
ketoconazole-treated AmB-resistant promastigotes, the methyl sterols
which accumulated were the cholesta-5, 7, 24-trien-3
-ol precursors
(i.e., 14
-methylcholesta-8, 24-dien-3
-ol). This confirms the
above-mentioned sterol biosynthesis pathway where the end product is
cholesta-5, 7, 24-trien-3
-ol instead of ergosterol.
The interaction of AmB with ergosterol leads to the formation of
transmembrane AmB channels which induce altered permeability to
cations, water, and glucose and affect membrane-bound enzyme (3,
15).
Optimum interaction between a sterol molecule and AmB requires a
3
-OH group, a flat steroid nucleus, and a hydrophobic side chain at
C-17 (17, 27). In addition, the length of the side chain
allowing maximum interaction of AmB with cholesterol or its analogs
containing dipalmitoylglycerophosphocholin liposomes must have more
than five carbon atoms (25).
Optimum ergosterol-AmB interaction would probably require similar
features in Leishmania or fungi. The minor modification of
sterol structure, i.e., absence of methyl group at C-24 or double bond
position in the side chain, would impair polyene-sterol interaction.
The structural characteristics of the end product of sterol
biosynthesis in AmB-resistant Leishmania fits this
hypothesis. Indeed, the major sterol of AmB-resistant
Leishmania differs from ergosterol of the wild type in
having an unmethylated short side chain with a double bond between C-24
and C-25 (
24-25).
The AmB efflux observed is probably related at least partially to this
weaker interaction.
Membrane fluidity is dependent on the sterol and phospholipid
composition of the membrane (2, 7). In opposite to the ordering effect of cholesterol, bulky C-24 methyl and the
22 double bond of ergosterol have a disordering effect
in artificial membranes (32) and in yeast (5).
S. cerevisiae mutants deficient in C-24 transmethylation
contain more ordered membranes than do wild types, as measured by
electron spin resonance (20). Moreover, it is commonly
assumed that the presence of saturated fatty acids increases the
ordered state of membranes (7, 17). Although saturated fatty
acids are in great excess in AmB-resistant promastigotes, the fluidity
of the membranes was found to be enhanced. Since the phospholipid
composition is not significantly affected by resistance, the
predominant effect on the membrane fluidity could be ascribed to
cholesta-5, 7, 24-trien-3
-ol. Using lecithin liposomes as a
biomimetic model, it has been demonstrated that the interaction between
AmB and the membrane demands that the membrane be in an ordered state
(low fluidity) (17). Our results confirm this requirement
since we observed both an increasing membrane fluidity and a decreasing
AmB sensitivity in AmB-resistant promastigotes. In the same study, it
was also demonstrated that cholesterol decreased the order of
dipalmitoyl-lecithin liposomes by reducing interactions between
hydrocarbon chains of phospholipids (17). In AmB-resistant promastigotes, cholesta-5, 7, 24-trien-3
-ol could act similarly with fatty acids.
These observations suggest that the high membrane fluidity of
AmB-resistant cells in comparison with the membrane fluidity of
sensitive cells is due mainly to the presence of cholesta-5, 7, 24-trien-3
-ol instead of ergosterol in the membranes.
In addition, the quantification of plasmic and intracytoplasmic lipids
by fluorescence measurements indicates that their biosynthesis also
undergoes some modifications in resistant cells.
Both AmB-sensitive and AmB-resistant promastigotes were infective for
macrophages in vitro, whereas only the sensitive strain was infective
in vivo. The greater microviscosity of parasite membranes is related to
the higher exposure of membrane surface structures such as
receptors, antigens, and enzymes (8). In AmB-resistant
parasites, microviscosity as measured by fluorescence anisotropy was
decreased. Therefore, membrane receptors were maybe not functional,
explaining the lack of infectivity in vivo.
This study shows that resistance of L. donovani
promastigotes to AmB involves the substitution of another sterol for
ergosterol in the cell membrane, change in membrane fluidity, and a
weak affinity of AmB for such modified membranes.
 |
ACKNOWLEDGMENT |
We thank S. L. Croft for critical reading of the manuscript.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Biologie et
Contrôle des Organismes Parasites, Faculté de Pharmacie,
Université de Paris-Sud, F-92296, Châtenay-Malabry, France.
Phone: 33 1 46 83 55 54. Fax: 33 1 46 83 55 57. E-mail:
philippe.loiseau{at}cep.u-psud.fr.
 |
REFERENCES |
| 1.
|
Berman, J. D.,
G. Ksionski,
W. L. Chapman,
V. B. Waits, and W. L. Hanson.
1992.
Activity of amphotericin B cholesterol dispersion (Amphocil) in experimental visceral leishmaniasis.
Antimicrob. Agents Chemother.
36:1978-1980[Abstract/Free Full Text].
|
| 2.
|
Bloch, K. E.
1983.
Sterol structure and membrane function.
Crit. Rev. Biochem.
14:47-92[Medline].
|
| 3.
|
Brajtburg, J., and J. Bolard.
1996.
Carrier effects on biological activity of amphotericin B.
Clin. Microbiol. Rev.
9:512-531[Abstract].
|
| 4.
|
Brassine, C.,
A. Laduron,
A. Coune,
J. P. Sculier,
C. Hollaert,
N. Collette, and F. Meunier.
1987.
High-performance liquid chromatographic determination of amphotericin B in human serum.
J. Chromatogr.
419:401-407[Medline].
|
| 5.
|
Buttke, T. M.,
S. D. Jones, and K. Bloch.
1980.
Effect of sterol side chains on growth and membrane fatty acid composition of Saccharomyces cerevisiae.
J. Bacteriol.
144:124-130[Abstract/Free Full Text].
|
| 6.
|
Davidson, R. N.,
S. L. Croft,
A. Scott,
M. Maini,
A. H. Moody, and A. D. M. Bryceson.
1991.
Liposomal amphotericin B in drug-resistant visceral leishmaniasis.
Lancet
337:1061-1062[Medline].
|
| 7.
|
Demel, R. A., and B. de Kruyff.
1976.
The function of sterols in membranes.
Biochim. Biophys. Acta
457:109-132[Medline].
|
| 8.
|
Dutta, M.,
R. Bandyopadhyay,
C. Ghosh, and M. K. Basu.
1990.
Fluidity-dependent Mg2+-ATPase activity in membranes from Leishmania promastigotes.
Biochem. J.
265:923-926[Medline].
|
| 9.
|
Fox, M. H., and T. M. Delohery.
1987.
Membrane fluidity measured by fluorescence polarization using an EPICS V cell sorter.
Cytometry
8:20-25[Medline].
|
| 10.
|
Galli, G., and S. Maroni.
1967.
Mass spectrometric investigations of some unsaturated sterols biosynthetically related to cholesterol.
Steroids
10:189-197[Medline].
|
| 11.
|
Gantet, P.,
C. Hubac, and S. C. Brown.
1990.
Flow cytometric fluorescence anisotropy of lipidic probes in epidermal and mesophyll protoplasts from water stressed Lupinius albus.
L. Plant Physiol.
94:729-737.
|
| 12.
|
Goad, L. J.,
G. G. Holtz, Jr., and D. H. Beach.
1984.
Sterols of Leishmania species. Implications for biosynthesis.
Mol. Biochem. Parasitol.
10:161-170[Medline].
|
| 13.
|
Goad, L. J.,
G. G. Holtz, Jr., and D. H. Beach.
1985.
Sterols of ketoconazole-inhibited Leishmania mexicana mexicana promastigotes.
Mol. Biochem. Parasitol.
15:257-279[Medline].
|
| 14.
|
Greespan, P.,
E. P. Mayer, and S. D. Fowler.
1985.
Nile red: a selective fluorescent stain for intracellular lipid droplets.
J. Cell Biol.
100:965-973[Abstract/Free Full Text].
|
| 15.
|
Hartsel, S., and J. Bolard.
1996.
Amphotericin B: new life for an old drug.
Trends Pharmacol. Sci.
17:445-449[Medline].
|
| 16.
|
Hebeka, E. K., and M. Solotorowsky.
1965.
Development of resistance to polyene antibiotics in Candida albicans.
J. Bacteriol.
89:1533-1539[Abstract/Free Full Text].
|
| 17.
|
Hsu Chen, C. C., and D. S. Feingold.
1973.
Polyene antibiotic action on lecithin liposomes: effect of cholesterol and fatty acyl chains.
Biochem. Biophys. Res. Commun.
51:972-978[Medline].
|
| 18.
|
Hülsewede, J. W., and H. Dermouni.
1994.
Comparison of high-performance liquid chromatography and bioassay of amphotericin B in serum.
Mycoses
37:17-21[Medline].
|
| 19.
|
Knights, B. A.
1967.
Identification of plant sterol using combined GLC/mass spectrometry.
J. Gas Chromatogr.
5:273-282.
|
| 20.
|
Lees, N. D.,
M. Bard,
M. D. Kemple,
R. A. Haak, and F. W. Kleinhans.
1979.
ESR determination of membrane order parameter in yeast sterol mutants.
Biochim. Biophys. Acta
553:469-475[Medline].
|
| 21.
|
Maarouf, M.,
F. Lawrence,
S. Brown, and M. Robert-Gero.
1997.
Biochemical alterations in paromomycin-treated Leishmania donovani promastigotes.
Parasitol. Res.
83:198-202[Medline].
|
| 22.
|
Massey, I. J., and C. Djerassi.
1979.
Structural and stereochemical applications of mass spectrometry in the marine sterol field. Synthesis and electron impact induced mass spectral fragmentation of 24 and 24(28)-3 -hydroxy- 5-sterols.
J. Org. Chem.
44:2448-2456.
|
| 23.
|
Mishra, M.,
V. Biswas,
D. Jha, and A. Khan.
1992.
Amphotericin versus pentamidine in antimony-unresponsive kala-azar.
Lancet
340:1256-1257[Medline].
|
| 24.
|
Mpona-Minga, M.,
A. Hakkou,
J. Coulon, and R. Bonaly.
1988.
Influence d'une dose subinhibitrice d'Amphotéricine B sur la composition en acides gras et stérols cellulaires de Candida albicans.
Ann. Inst. Pasteur/Microbiol.
139:547-555.
|
| 25.
|
Nakamura, T.,
M. Nishikawa,
K. Inoue,
S. Nojima,
T. Akiyama, and U. Sankawa.
1980.
Phosphatidylcholine liposomes containing cholesterol analogues with side chains of various lengths.
Chem. Phys. Lipids
26:101-110[Medline].
|
| 26.
|
Navin, T. R.,
B. A. Arana,
F. E. Arana,
J. D. Berman, and J. F. Chajon.
1992.
Placebo controlled clinical trial of sodium stibogluconate (pentostam) versus ketoconazole for treating cutaneous leishmaniasis in Guatemala.
J. Infect. Dis.
165:528-534[Medline].
|
| 27.
|
Norman, A. W.,
R. A. Demel,
B. DeKruijff, and L. L. M. Van Deenen.
1972.
Studies on the biological properties of polyene antibiotics. Evidence for the direct interaction of Filipin with cholesterol.
J. Biol. Chem.
247:1918-1929[Abstract/Free Full Text].
|
| 28.
|
Pearson, R. D., and A. D. Sousa.
1996.
Clinical spectrum of leshmaniasis.
Clin. Infect. Dis.
22:1-11[Medline].
|
| 29.
|
Phelouzat, M. A.,
F. Lawrence, and M. Robert-Gero.
1993.
Characterization of sinefungin-resistant Leishmania donovani promastigotes.
Parasitol. Res.
79:683-689[Medline].
|
| 30.
|
Rodes, J. F.,
J. Berreur-Bonnenfant,
A. Trémolières, and C. B. Spencer.
1995.
Modulation of membrane fluidity and lipidic metabolism in transformed rat fibroblasts induced by the sesquiterpenic hormone farnesylacetone.
Cytometry
19:217-225[Medline].
|
| 31.
|
Russo, R.,
L. C. Nigro,
S. Minniti,
A. Montineri,
L. Gradoni,
L. Caldeira, and R. N. Davidson.
1996.
Visceral leishmaniasis in HIV-infected patients: treatment with high dose liposomal Amphotericin B (AmBisome).
J. Infect.
32:133-137[Medline].
|
| 32.
|
Semer, R., and E. Gelerinter.
1979.
A spin label study of the effects of sterols on egg lecithin bilayers.
Chem. Phys. Lipids
23:201-211.
|
| 33.
|
Thakur, C. P.,
M. Kumar, and A. Pandey.
1991.
Comparison of regimens of treatment of antimony-resistant kala-azar patients: a randomized study.
Am. J. Trop. Med. Hyg.
45:435-441.
|
| 34.
|
Vanden Bossche, H.,
P. Marichal, and F. Odds.
1994.
Molecular mechanisms of drug resistance in fungi.
Trends Microbiol.
10:393-400.
|
Antimicrobial Agents and Chemotherapy, February 1998, p. 352-357, Vol. 42, No. 2
0066-4804/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Saint-Pierre-Chazalet, M., Ben Brahim, M., Le Moyec, L., Bories, C., Rakotomanga, M., Loiseau, P. M.
(2009). Membrane sterol depletion impairs miltefosine action in wild-type and miltefosine-resistant Leishmania donovani promastigotes. J Antimicrob Chemother
64: 993-1001
[Abstract]
[Full Text]
-
Vermeersch, M., da Luz, R. I., Tote, K., Timmermans, J.-P., Cos, P., Maes, L.
(2009). In Vitro Susceptibilities of Leishmania donovani Promastigote and Amastigote Stages to Antileishmanial Reference Drugs: Practical Relevance of Stage-Specific Differences. Antimicrob. Agents Chemother.
53: 3855-3859
[Abstract]
[Full Text]
-
Rakotomanga, M., Blanc, S., Gaudin, K., Chaminade, P., Loiseau, P. M.
(2007). Miltefosine Affects Lipid Metabolism in Leishmania donovani Promastigotes. Antimicrob. Agents Chemother.
51: 1425-1430
[Abstract]
[Full Text]
-
Croft, S. L., Sundar, S., Fairlamb, A. H.
(2006). Drug Resistance in Leishmaniasis. Clin. Microbiol. Rev.
19: 111-126
[Abstract]
[Full Text]
-
Al-Mohammed, H. I., Chance, M. L., Bates, P. A.
(2005). Production and Characterization of Stable Amphotericin-Resistant Amastigotes and Promastigotes of Leishmania mexicana. Antimicrob. Agents Chemother.
49: 3274-3280
[Abstract]
[Full Text]
-
Rakotomanga, M., Saint-Pierre-Chazalet, M., Loiseau, P. M.
(2005). Alteration of Fatty Acid and Sterol Metabolism in Miltefosine-Resistant Leishmania donovani Promastigotes and Consequences for Drug-Membrane Interactions. Antimicrob. Agents Chemother.
49: 2677-2686
[Abstract]
[Full Text]
-
Mangoni, M. L., Saugar, J. M., Dellisanti, M., Barra, D., Simmaco, M., Rivas, L.
(2005). Temporins, Small Antimicrobial Peptides with Leishmanicidal Activity. J. Biol. Chem.
280: 984-990
[Abstract]
[Full Text]
-
Pourshafie, M., Morand, S., Virion, A., Rakotomanga, M., Dupuy, C., Loiseau, P. M.
(2004). Cloning of S-Adenosyl-L-Methionine:C-24-{Delta}-Sterol-Methyltransferase (ERG6) from Leishmania donovani and Characterization of mRNAs in Wild-Type and Amphotericin B-Resistant Promastigotes. Antimicrob. Agents Chemother.
48: 2409-2414
[Abstract]
[Full Text]
-
Larabi, M., Yardley, V., Loiseau, P. M., Appel, M., Legrand, P., Gulik, A., Bories, C., Croft, S. L., Barratt, G.
(2003). Toxicity and Antileishmanial Activity of a New Stable Lipid Suspension of Amphotericin B. Antimicrob. Agents Chemother.
47: 3774-3779
[Abstract]
[Full Text]
-
Loiseau, P. M., Imbertie, L., Bories, C., Betbeder, D., De Miguel, I.
(2002). Design and Antileishmanial Activity of Amphotericin B-Loaded Stable Ionic Amphiphile Biovector Formulations. Antimicrob. Agents Chemother.
46: 1597-1601
[Abstract]
[Full Text]
-
Espuelas, S., Legrand, P., Loiseau, P. M., Bories, C., Barratt, G., Irache, J. M.
(2000). In Vitro Reversion of Amphotericin B Resistance in Leishmania donovani by Poloxamer 188. Antimicrob. Agents Chemother.
44: 2190-2192
[Abstract]
[Full Text]
-
DANNAOUI, E., BOREL, E., PERSAT, F., PIENS, M.A., PICOT, S.
(2000). Amphotericin B resistance of Aspergillus terreus in a murine model of disseminated aspergillosis. J Med Microbiol
49: 601-606
[Abstract]
[Full Text]
-
Ghannoum, M. A., Rice, L. B.
(1999). Antifungal Agents: Mode of Action, Mechanisms of Resistance, and Correlation of These Mechanisms with Bacterial Resistance. Clin. Microbiol. Rev.
12: 501-517
[Abstract]
[Full Text]
-
Di Giorgio, C., Faraut-Gambarelli, F., Imbert, A., Minodier, P., Gasquet, M., Dumon, H.
(1999). Flow cytometric assessment of amphotericin B susceptibility in Leishmania infantumisolates from patients with visceral leishmaniasis. J Antimicrob Chemother
44: 71-76
[Abstract]
[Full Text]
-
Gangneux, J.-P., Dullin, M., Sulahian, A., Garin, Y. J.-F., Derouin, F.
(1999). Experimental Evaluation of Second-Line Oral Treatments of Visceral Leishmaniasis Caused by Leishmania infantum. Antimicrob. Agents Chemother.
43: 172-174
[Abstract]
[Full Text]